Revolution Medicines, Inc.

Healthcare

NASDAQ:RVMD · NASDAQ Global Select

Market Cap $34.03B Beta 1.41 P/E (TTM) -23.3

$162.99 +2.28%

+$3.60 today

52W Low $34.00High $166.50

Vol 4.01M · Avg 3.10M

EPS (TTM) -$6.92Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+307.07%

Period High

$163.68

Period Low

$34.70

Latest

$162.99

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Moderna, Inc.

NASDAQ:MRNA

$25.23B

Roivant Sciences Ltd.

NASDAQ:ROIV

$22.43B

Ascendis Pharma A/S

NASDAQ:ASND

$14.35B

BridgeBio Pharma, Inc.

NASDAQ:BBIO

$13.10B

Exelixis, Inc.

NASDAQ:EXEL

$13.03B

Ionis Pharmaceuticals, Inc.

NASDAQ:IONS

$12.28B

Madrigal Pharmaceuticals, Inc.

NASDAQ:MDGL

$11.63B

Summit Therapeutics Inc.

NASDAQ:SMMT

$10.73B

BioMarin Pharmaceutical Inc.

NASDAQ:BMRN

$10.59B

Atrium Therapeutics, Inc.

NASDAQ:RNA

$217.07M

What is the latest RVMD filing?

The latest filing shown is 4 dated Jun 17, 2026.

How many recent filings does RVMD have?

Intrinsic Alpha currently shows 20 recent filings for RVMD.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.